ISSN: 2329-9053

Journal of Molecular Pharmaceutics & Organic Process Research
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Commentary   
  • J Mol Pharm Org Process Res 2024, Vol 12(4): 239

Nanoparticle-Mediated Gene Therapy: Innovations and Future Directions

Zhiqiang Jiang*
College of Pharmacy, Zhejiang Chinese Medical University, China
*Corresponding Author : Zhiqiang Jiang, College of Pharmacy, Zhejiang Chinese Medical University, China, Email: stanger.gadella@gmail.com

Received Date: Jul 01, 2024 / Published Date: Jul 29, 2024

Abstract

Gene therapy holds tremendous promise for treating genetic disorders and complex diseases by delivering therapeutic genes to target cells. Nanoparticles have emerged as versatile carriers for gene delivery, offering protection of nucleic acids, controlled release, and targeted delivery to specific tissues. This article reviews recent innovations in nanoparticle-mediated gene therapy, highlighting design strategies, delivery mechanisms, and future directions for advancing clinical applications.

Citation: Zhiqiang J (2024) Nanoparticle-Mediated Gene Therapy: Innovations and Future Directions. J Mol Pharm Org Process Res 12: 239.

Copyright: © 2024 Zhiqiang J. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Top